| pubmed-article:20560575 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20560575 | lifeskim:mentions | umls-concept:C0998924 | lld:lifeskim |
| pubmed-article:20560575 | lifeskim:mentions | umls-concept:C0220781 | lld:lifeskim |
| pubmed-article:20560575 | lifeskim:mentions | umls-concept:C1883254 | lld:lifeskim |
| pubmed-article:20560575 | lifeskim:mentions | umls-concept:C0449445 | lld:lifeskim |
| pubmed-article:20560575 | pubmed:issue | 16 | lld:pubmed |
| pubmed-article:20560575 | pubmed:dateCreated | 2010-6-21 | lld:pubmed |
| pubmed-article:20560575 | pubmed:abstractText | The efficient Suzuki cross-coupling of pyrazoline nonaflates with organoboron reagents was achieved to afford diverse 3-substituted-2-pyrazolines in excellent yield. The nonaflates displayed improved reactivity over the corresponding triflates and smoothly coupled to a variety of aryl- and heteroarylboronic acids. This process and its broad scope constitute a rapid, divergent strategy for the synthesis of elaborated 2-pyrazolines that are not readily obtained via conventional methods. | lld:pubmed |
| pubmed-article:20560575 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20560575 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20560575 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20560575 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20560575 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20560575 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20560575 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20560575 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:20560575 | pubmed:issn | 1520-6904 | lld:pubmed |
| pubmed-article:20560575 | pubmed:author | pubmed-author:WilsonKevin... | lld:pubmed |
| pubmed-article:20560575 | pubmed:author | pubmed-author:GrimmJonathan... | lld:pubmed |
| pubmed-article:20560575 | pubmed:author | pubmed-author:WitterDavid... | lld:pubmed |
| pubmed-article:20560575 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20560575 | pubmed:day | 21 | lld:pubmed |
| pubmed-article:20560575 | pubmed:volume | 74 | lld:pubmed |
| pubmed-article:20560575 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20560575 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20560575 | pubmed:pagination | 6390-3 | lld:pubmed |
| pubmed-article:20560575 | pubmed:meshHeading | pubmed-meshheading:20560575... | lld:pubmed |
| pubmed-article:20560575 | pubmed:meshHeading | pubmed-meshheading:20560575... | lld:pubmed |
| pubmed-article:20560575 | pubmed:meshHeading | pubmed-meshheading:20560575... | lld:pubmed |
| pubmed-article:20560575 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:20560575 | pubmed:articleTitle | A divergent approach to the synthesis of 3-substituted-2-pyrazolines: Suzuki cross-coupling of 3-sulfonyloxy-2-pyrazolines. | lld:pubmed |
| pubmed-article:20560575 | pubmed:affiliation | Department of Chemistry, Merck Research Laboratories, Boston, Massachusetts 02115, USA. jonathan_grimm@merck.com | lld:pubmed |
| pubmed-article:20560575 | pubmed:publicationType | Journal Article | lld:pubmed |
